UBS Group’s MiniMed Group Inc MMED Stock Holding History

UBS Group’s Portfolio MMED Stock Details MMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.79M	Buy	+400,000	New	+$7.69M	﹤0.01%	3646

Other funds holding MMED

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

UBS Group's MMED Position: Q3 2026 in Review

UBS Group increased its MiniMed Group Inc (MMED) stake by 562% in Q3 2026, buying an estimated $44.6M and bringing the position to 2,736,650 shares worth $53.3M. The position accounts for 0.01% of the portfolio, ranked #1638.

UBS Group first reported a position in MMED in Q1 2026 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold MMED as of Q3 2026.

UBS Group held 2,736,650 shares of MiniMed Group Inc worth $53.3M as of Q3 2026.
UBS Group bought 2,323,234 MiniMed Group Inc shares in Q3 2026, an estimated $44.6M.
MiniMed Group Inc made up 0.01% of UBS Group's portfolio in Q3 2026, its #1638 holding.
UBS Group first reported a position in MiniMed Group Inc in Q1 2026 and has held it in 3 quarters since.
93 funds tracked by Wall St. Rank held MiniMed Group Inc as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.